Suppr超能文献

通过密度泛函理论计算和分子动力学模拟深入了解新型 HSP90 抑制剂的结构和动态特性。

Insight into the structural and dynamic properties of novel HSP90 inhibitors through DFT calculations and molecular dynamics simulations.

机构信息

Department of Chemistry, Laboratory of Organic Synthesis and Modeling Group (LOMOP), University of Badji-Mokhtar, 23000, Annaba, Algeria.

Department of Chemistry, Laboratory of Applied Chemistry and Renewable Energies (LACRE), University of Echahid Cheikh Larbi Tebessi, 12000, Tebessa, Algeria.

出版信息

J Mol Model. 2024 Nov 27;30(12):420. doi: 10.1007/s00894-024-06214-6.

Abstract

CONTEXT

Heat-shock proteins (HSPs), particularly HSP90, are critical molecular chaperones that maintain protein stability, especially in cancer cells. Elevated HSP90 levels in tumors aid in oncogenic protein stabilization. This study focuses on developing potent, selective HSP90 inhibitors to disrupt its chaperone function, targeting cancer cell survival. Using a de novo hybridization approach, we designed novel inhibitors by integrating structural fragments from a known HSP90-binding drug, leading to the creation of hybrid compounds C1, C2, and C3. A 300 ns molecular dynamics simulation of each system revealed that C1, C2, and C3 formed more stable complexes with HSP90 compared to the reference compound, MEY. RMSD, RMSF, Rg, SASA, and MM-PBSA metrics supported these findings. DCCM and FEL analyses confirmed that the inhibitors did not alter HSP90's initial configuration. Further DFT calculations with the B3LYP/6-311 +  + (d,p) basis set were conducted to evaluate frontier molecular orbitals, MEP surfaces, ELF, LOL maps, TDOS and PDOS. The results indicated that C1, C2, and C3 formed more stable complexes with HSP90 compared to the reference compound MEY. These findings affirm the potential of C1, C2, and C3 as new anti-cancer therapies. Our approach demonstrates a promising strategy for developing selective HSP90 inhibitors that maintain the protein's functional integrity while disrupting its oncogenic role, paving the way for further preclinical evaluation of these novel compounds.

METHODS

Maestro 11.8, Discovery Studio Visualizer, Gromacs-2023, Gaussian 16, and online platforms like SwissADME and ProTox-II were utilized. Fragments generated from eight known HSP90-binding drugs were subjected to SP-docking, leading to 170 fragments. The highest-scoring fragments were merged using the breed panel to create new HSP90 inhibitors. XP-docking and ADMET analyses identified C1, C2, and C3 as the most promising candidates. These compounds were selected for a 300 ns dynamic simulation and subsequent DFT calculations.

摘要

背景

热休克蛋白(HSPs),特别是 HSP90,是维持蛋白质稳定性的关键分子伴侣,特别是在癌细胞中。肿瘤中 HSP90 水平的升高有助于致癌蛋白的稳定。本研究旨在开发有效的、选择性的 HSP90 抑制剂,以破坏其伴侣功能,针对癌细胞的存活。我们采用从头杂交方法,通过整合已知 HSP90 结合药物的结构片段,设计了新型抑制剂,从而产生了混合化合物 C1、C2 和 C3。对每个系统进行 300ns 的分子动力学模拟表明,与参考化合物 MEY 相比,C1、C2 和 C3 与 HSP90 形成了更稳定的复合物。RMSD、RMSF、Rg、SASA 和 MM-PBSA 指标支持这些发现。DCCM 和 FEL 分析证实,抑制剂没有改变 HSP90 的初始构象。进一步使用 B3LYP/6-311++(d,p)基组进行 DFT 计算,以评估前沿分子轨道、MEP 表面、ELF、LOL 图、TDOS 和 PDOS。结果表明,与参考化合物 MEY 相比,C1、C2 和 C3 与 HSP90 形成了更稳定的复合物。这些发现证实了 C1、C2 和 C3 作为新型抗癌疗法的潜力。我们的方法展示了一种有前途的策略,用于开发选择性 HSP90 抑制剂,在破坏其致癌作用的同时保持蛋白质的功能完整性,为这些新型化合物的进一步临床前评估铺平了道路。

方法

使用 Maestro 11.8、Discovery Studio Visualizer、Gromacs-2023、Gaussian 16 以及 SwissADME 和 ProTox-II 等在线平台。从八种已知 HSP90 结合药物中生成的片段进行 SP 对接,得到 170 个片段。使用 breed 面板对得分最高的片段进行合并,创建新的 HSP90 抑制剂。XP 对接和 ADMET 分析确定 C1、C2 和 C3 为最有前途的候选物。选择这些化合物进行 300ns 动力学模拟和随后的 DFT 计算。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验